Clinical Trial Update: Nesiritide in Resistant Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of Nesiritide for resistant hypertension was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Resistant Hypertension

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: John C Burnett | Conditions: Hypertension | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-10-20